Evidence map›Paper›PMID 30720908›Full record

ArticleStem cells (Dayton, Ohio)2019

Sox2 Expression Marks Castration-Resistant Progenitor Cells in the Adult Murine Prostate.

Erin McAuley, Daniel Moline, Calvin VanOpstall, Sophia Lamperis, Ryan Brown, Donald J Vander Griend

Open access · bronzeAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. The role of Trop2 in prostate cancer: an oncogene, biomarker, and therapeutic target.American journal of clinical and experimental urology · 2021
    Article
  15. Article
  16. The Sca-1Stem cells (Dayton, Ohio) · 2020
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Erin McAuleyThe Committee on Molecular Pathogenesis and Molecular Medicine, The University of Chicago, Chicago, Illinois, USA.ORCID 0000-0003-3911-4390
Daniel MolineThe Committee on Development, Regeneration, and Stem Cell Biology, The University of Chicago, Chicago, Illinois, USA.
Calvin VanOpstallThe Committee on Cancer Biology, The University of Chicago, Chicago, Illinois, USA.
Sophia LamperisDepartment of Surgery, Section of Urology, The University of Chicago, Chicago, Illinois, USA.
Ryan BrownDepartment of Surgery, Section of Urology, The University of Chicago, Chicago, Illinois, USA.
Donald J Vander GriendDepartment of Surgery, Section of Urology, The University of Chicago, Chicago, Illinois, USA.ORCID 0000-0003-4421-5698
University of Chicago · USUniversity of Illinois Chicago · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI CHIEN-MIN KAO · 1985 to 2026
$122.1M
Molecular And Cellular Biology Training ProgramT32GM007183 · NIGMS · UNIVERSITY OF CHICAGO · PI GLICK, BENJAMIN S, RICE, PHOEBE A · 1985 to 2021
$23.9M
Multi-Disciplinary Training Grant in Cancer ResearchT32CA009594 · NCI · UNIVERSITY OF CHICAGO · PI KAY F MACLEOD, Scott A. Oakes · 1989 to 2026
$11.5M
Function of the Stem Cell Transcription Factor Sox2 in Prostate CancerR01CA178431 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI VANDER GRIEND, DONALD JAMES · 2014 to 2018
$1.9M
The Role of Sox2 in prostate epithelium development, regeneration and hyperplasiaF31DK111131 · NIDDK · UNIVERSITY OF CHICAGO · PI MCAULEY, ERIN · 2016 to 2017
$76k
Disruption of MEIS1-HOXB13 interaction as a detrimental event in prostate cancer initiation and progressionF31CA232651 · NCI · UNIVERSITY OF CHICAGO · PI VANOPSTALL, CALVIN SCOTT · 2018 to 2018
$45k
NCI NIH HHS F31 CA232651NCI NIH HHS P30 CA014599NCI NIH HHS R01 CA178431NCI NIH HHS T32 CA009594NIDDK NIH HHS F31 DK111131NIGMS NIH HHS T32 GM007183
6 · The paper itself

Abstract

Identification of defined epithelial cell populations with progenitor properties is critical for understanding prostatic development and disease. Here, we demonstrate that Sox2 expression is enriched in the epithelial cells of the proximal prostate adjacent to the urethra. We use lineage tracing of Sox2-positive cells during prostatic development, homeostasis, and regeneration to show that the Sox2 lineage is capable of self-renewal and contributes to prostatic regeneration. Persisting luminal cells express Sox2 after castration, highlighting a potential role for Sox2 in cell survival and castration-resistance. In addition to revealing a novel progenitor population in the prostate, these data implicate Sox2 as a regulatory factor of adult prostate epithelial stem cells. Stem Cells 2019;37:690-700.

Indexed as

Stem CellsAdult Stem CellsAnimalsCell LineageCell ProliferationDisease Models, AnimalEpithelial CellsHumansMaleMiceProstateProstatic Neoplasms, Castration-ResistantRegenerationSOXB1 Transcription FactorsSox2 protein, mouseSOXB1 Transcription FactorsProstateRegenerationSox2Stem cell

Identifiers

PMID30720908
PMCPMC6499382
OpenAlexW2914150465

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.